Why the study?
Does age influence the responsiveness of medium-sized veins to local infusions of nitroglycerin in healthy male volunteers?
Does age influence the responsiveness of medium-sized veins to local infusions of nitroglycerin in healthy male volunteers?
Unlike beta-receptor agonist-mediated venodilation, venous responsiveness to nitroglycerin does not decline with increasing age in healthy humans.
Answers are grounded in this paper and cite their sources.
Preserved nitroglycerin venodilation across ages in healthy men; supports differential pathway aging effects but leaves open relevance in disease.
We have previously demonstrated a progressive loss in the ability of the beta-receptor agonist isoproterenol to relax veins with increasing age. In this study the influence of age on the responsiveness of medium-sized veins to local infusions of nitroglycerin was studied in two groups of 15 healthy male volunteers using the dorsal hand vein compliance technique. A dorsal hand vein was preconstricted with submaximally effective doses of phenylephrine and a dose-response curve with nitroglycerin was established. The nitroglycerin dose that caused a 50% venodilation ranged from 0.7 to 22.4 ng/min (geometric mean 3.6 ng/min) in the younger group (aged 19 to 29 years; mean +/- SD 23 +/- 3 years) and from 0.2 to 17.9 ng/min (geometric mean 3.6 ng/min) in the older subjects (aged 50 to 74 years; mean +/- SD 63 +/- 7 years) (P = 0.49 between geometric means). The mean (+/- SD) maximal venodilation, based on the pretreatment baseline, was 103% +/- 65% in the younger and 125% +/- 64% in the older subjects (P = 0.18). These results indicate that there is no age-related change in venous responsiveness to nitroglycerin.
No takes yet. Share an insight, caveat, or question.
Eichler et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: